🚀

오늘의 열정을 계속 이어가세요!

체험은 만족하셨나요? 지식 자료를 소장하고 멋진 의료인으로 성장하세요!

구경하기
Antigout Medications | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

제안하기
닫기
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Antigout Medications

NCLEX Review Guide: Gout Medications

Pathophysiology of Gout

Understanding Gout Mechanism

  • Gout is characterized by the deposition of monosodium urate crystals in joints and tissues due to hyperuricemia (serum uric acid levels >6.8 mg/dL). The condition results from either overproduction of uric acid or underexcretion by the kidneys.
  • Acute gout attacks involve an inflammatory response to crystal deposition, typically affecting the first metatarsophalangeal joint (podagra), though other joints may be affected including ankles, knees, wrists, and fingers.

Key Points

  • Hyperuricemia is the primary cause of gout (>6.8 mg/dL)
  • Gout medications target either inflammation, uric acid production, or uric acid excretion

Acute Gout Attack Medications

NSAIDs

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin, naproxen, and ibuprofen are first-line treatments for acute gout attacks. They work by inhibiting cyclooxygenase enzymes, reducing prostaglandin synthesis and decreasing inflammation.
  • NSAIDs should be initiated at higher doses during acute attacks and tapered as symptoms resolve, typically within 7-10 days of treatment.

Key Points

  • Indomethacin (Indocin) is traditionally the preferred NSAID for acute gout
  • NSAIDs are contraindicated in patients with renal dysfunction, peptic ulcer disease, or heart failure

IMPORTANT: Monitor for GI bleeding, renal function changes, and cardiovascular effects with NSAID therapy. Administer with food to reduce GI irritation.

Colchicine

  • Colchicine is an anti-inflammatory agent that inhibits microtubule polymerization in neutrophils, preventing their migration to inflamed areas and reducing the inflammatory response to urate crystals.
  • Current dosing protocol recommends 1.2 mg at first sign of attack, followed by 0.6 mg one hour later (total 1.8 mg), which differs from older high-dose protocols that caused significant GI toxicity.

Key Points

  • Most effective when administered within 24-36 hours of attack onset
  • Dose must be adjusted for renal impairment and with certain drug interactions

Clinical Scenario

A 65-year-old male with a history of gout presents with severe pain and swelling in his right first metatarsophalangeal joint. He also has CKD stage 3. What medication adjustment is needed?

Answer: Colchicine dose should be reduced due to renal impairment (avoid if CrCl <30 mL/min), and NSAIDs should be avoided. Corticosteroids would be a safer alternative.

Corticosteroids

  • Systemic corticosteroids (prednisone, methylprednisolone) or intra-articular corticosteroid injections are effective alternatives for acute gout attacks, especially when NSAIDs or colchicine are contraindicated.
  • Oral prednisone is typically administered at 30-40 mg daily for 3-5 days, followed by a gradual taper over 10-14 days to prevent rebound attacks.

Key Points

  • Preferred in patients with renal insufficiency or NSAID contraindications
  • Intra-articular injections provide targeted relief with fewer systemic effects

Chronic Gout Management Medications

Xanthine Oxidase Inhibitors

  • Allopurinol (Zyloprim) inhibits xanthine oxidase, the enzyme responsible for converting xanthine to uric acid, thereby reducing uric acid production. It is the most commonly used urate-lowering therapy and is dosed based on renal function.
  • Febuxostat (Uloric) is a newer, more selective xanthine oxidase inhibitor that may be used in patients with mild to moderate renal impairment or those who cannot tolerate allopurinol.

Memory Aid: "ALLO-Prevents-ALL-Over production"

ALLOpurinol prevents ALL-Over production of uric acid by inhibiting xanthine oxidase.

Key Points

  • Start at low doses (allopurinol 100 mg daily) and gradually increase to minimize flare risk
  • Target serum uric acid level <6 mg/dL (or <5 mg/dL in severe gout)
  • Allopurinol hypersensitivity syndrome is rare but potentially fatal

IMPORTANT: Never initiate xanthine oxidase inhibitors during an acute gout attack as they may worsen or prolong the attack. Wait until 2-4 weeks after resolution.

Uricosuric Agents

  • Probenecid increases renal excretion of uric acid by inhibiting tubular reabsorption of urate in the proximal convoluted tubule. It is used for patients who underexcrete uric acid (approximately 80% of gout patients).
  • Probenecid is contraindicated in patients with uric acid kidney stones, creatinine clearance <50 mL/min, or those who are overproducers of uric acid.

Memory Aid: "PRO-benecid PRO-motes Pee-ing out uric acid"

PRO-benecid PRO-motes urinary excretion (Pee-ing out) of uric acid.

Key Points

  • Requires adequate hydration (2-3 L/day) to prevent uric acid stone formation
  • Interacts with many medications including penicillins, cephalosporins, and NSAIDs

Recombinant Uricase

  • Pegloticase (Krystexxa) is a pegylated recombinant uricase that converts uric acid to allantoin, which is more soluble and easily excreted by the kidneys. It is reserved for severe, refractory chronic gout.
  • Administered as an intravenous infusion every two weeks, pegloticase can rapidly lower serum uric acid levels but carries a high risk of infusion reactions and development of antibodies.

Key Points

  • Used only in severe, treatment-refractory gout
  • Premedication with antihistamines and corticosteroids recommended
  • Monitor for infusion reactions and anaphylaxis

Commonly Confused Medications

Differentiating Gout Medications

Medication Class Examples Mechanism Use Key Nursing Considerations
NSAIDs Indomethacin, Naproxen Inhibit COX enzymes Acute attacks Monitor for GI bleeding, renal effects
Colchicine Colcrys Inhibits microtubule polymerization Acute attacks GI side effects, dose reduction in renal impairment
Xanthine Oxidase Inhibitors Allopurinol, Febuxostat Decrease uric acid production Chronic management Start low, titrate slowly, monitor LFTs
Uricosuric Agents Probenecid Increase uric acid excretion Chronic management Encourage hydration, ineffective in renal impairment

Key Differences

  • Allopurinol and febuxostat reduce uric acid production while probenecid increases excretion
  • NSAIDs and colchicine treat acute inflammation but don't affect uric acid levels
  • Prophylactic colchicine (low dose) can prevent flares when initiating urate-lowering therapy

Administration and Nursing Considerations

Medication Administration

  1. Assess baseline renal and hepatic function before initiating gout medications
  2. Document pain level and affected joint characteristics (redness, swelling, warmth)
  3. Administer acute gout medications as soon as possible after symptom onset
  4. Provide appropriate patient education regarding medication purpose and side effects
  5. Implement non-pharmacological interventions (joint rest, elevation, cold application)
  6. Monitor for adverse effects specific to the medication class
  7. Assess therapeutic response through pain relief and decreased inflammation

Key Points

  • Administer colchicine with caution in elderly or those with renal/hepatic impairment
  • Ensure adequate hydration when administering uricosuric agents
  • Monitor serum uric acid levels regularly for patients on chronic therapy

Patient Education

  • Educate patients about the importance of medication adherence for chronic gout management, emphasizing that urate-lowering therapy is typically lifelong and that discontinuation can trigger acute attacks.
  • Counsel patients about dietary modifications that may help manage gout, including limiting high-purine foods (organ meats, shellfish, beer), maintaining adequate hydration, and moderating alcohol intake.

Key Points

  • Emphasize importance of taking prophylactic medication when starting urate-lowering therapy
  • Teach patients to recognize early signs of gout flare for prompt treatment
  • Stress the importance of regular uric acid monitoring

Common Pitfalls

  • Starting urate-lowering therapy during an acute attack (wait until 2-4 weeks after resolution)
  • Failing to provide prophylaxis when initiating urate-lowering therapy
  • Discontinuing allopurinol during an acute attack (should be continued)
  • Using probenecid in patients with renal insufficiency or history of kidney stones

Study Tips for NCLEX Success

Focus Areas for Gout Medications

  • Prioritize understanding the mechanisms of action for each drug class and how they relate to gout pathophysiology.
  • Master the contraindications and major adverse effects of each medication, especially those requiring immediate nursing intervention.

Acute vs. Chronic Treatment Memory Aid: "ICE for Acute, APU for Chronic"

I = Indomethacin/NSAIDs
C = Colchicine
E = stEroids (corticosteroids)

A = Allopurinol/febuxostat
P = Probenecid
U = Uricase (pegloticase)

Quick Check

Which medication should never be initiated during an acute gout attack?

Answer: Allopurinol or other urate-lowering therapies should not be initiated during an acute attack as they may worsen or prolong symptoms.

Self-Assessment

I can explain the mechanism of action for:

NSAIDs in gout treatment
Colchicine
Allopurinol and febuxostat
Probenecid
Pegloticase

I understand:

The difference between acute and chronic gout management
Major contraindications for each gout medication
Appropriate nursing interventions for gout medication side effects
Patient education priorities for gout management

Remember, understanding gout medications requires connecting pathophysiology with pharmacological interventions. Master the mechanisms of action and you'll be well-prepared for NCLEX questions on this topic. You've got this!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.